This is a Scorecard review, revisiting a past LF0 research call against what actually happened.
Ticker: WGS Rating: Sell Published: 2026-08-09 Checkpoint: 2026-09-09 Entry price: $77.88 Latest price: $85.87 as of 2026-09-08 Stock return since entry: +10.3% Signal return: -10.3% Verdict: Incorrect so far
This is the 1-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.
Read the original LF0 analysis
What I Said
I rated WGS a Sell because I thought the business quality was better than it used to be, but the operating results still weren’t converting that moat into self-funding earnings. The specific issues I focused on were the 69.4% gross margin looking healthy while TTM operating margin was still -15.2% and free cash flow margin was -10.5%, which told me overhead, collections, and reimbursement were still absorbing too much of the value. I also said I wanted to see revenue growth reaccelerate into the high teens and accounts receivable stop growing faster than revenue before I would soften that view.
Peer Comparison
| Company | Return Since Entry |
|---|---|
| WGS (this call) | +10.3% |
| FLGT | +4.1% |
| GH | -2.6% |
| NTRA | +3.7% |
| TEM | +11.3% |
| VEEV | +11.2% |
Why It’s Working (Or Not)
So far, following my Sell would have lost money: the stock is up about 10.3% since entry, so a short would be down by the same amount. That means my bearish timing has not worked yet, even though the original thesis was specific rather than vague. The peer set has been mixed to higher over the same stretch, with several comparables also moving up, so WGS has not clearly diverged in the way I would have needed to validate a short thesis. What has not been validated yet is my claim that the valuation was being supported by an earnings and cash-flow inflection that was not actually arriving; I do not have evidence from this month’s price action that the margin and cash-generation concerns have started to dominate.
What Could Still Prove Me Wrong
What could still prove me wrong is a sustained improvement in the exact operating metrics I flagged: revenue growth moving into the high teens, free cash flow turning positive, and accounts receivable no longer outpacing revenue. If those trends show up together, then my concern that the moat was not translating into self-funding earnings would be weakened. If instead the company keeps burning cash at roughly the same pace while growth stalls, that would support the original bearish case, but the stock’s current move has not yet given me that confirmation.
The August 2026 Cohort
Other directional calls published the same month:
| Ticker | Rating | Entry | Latest | Stock Return | Signal Return | Verdict |
|---|---|---|---|---|---|---|
| SDGR | Sell | $17.40 | $20.03 | +15.1% | -15.1% | Incorrect so far |
| VNOM | Sell | $41.67 | $44.89 | +7.7% | -7.7% | Incorrect so far |
| ALT | Sell | $3.15 | $3.36 | +6.7% | -6.7% | Incorrect so far |
| NXE | Sell | $10.40 | $10.69 | +2.8% | -2.8% | Incorrect so far |
| AES | Sell | $14.71 | $14.83 | +0.8% | -0.8% | Incorrect so far |
| BA | Sell | $210.46 | $210.73 | +0.1% | -0.1% | Incorrect so far |
| OI | Sell | $6.79 | $6.75 | -0.6% | +0.6% | Correct so far |
| NUTX | Buy | $188.41 | $190.66 | +1.2% | +1.2% | Correct so far |
| LHX | Sell | $260.92 | $255.74 | -2.0% | +2.0% | Correct so far |
| ADTN | Sell | $7.76 | $7.58 | -2.3% | +2.3% | Correct so far |
| GTN | Sell | $4.91 | $4.77 | -2.9% | +2.9% | Correct so far |
| SPHR | Sell | $147.34 | $142.41 | -3.3% | +3.3% | Correct so far |
| SRG | Strong Sell | $2.11 | $2.04 | -3.3% | +5.0% | Correct so far |
| NNDM | Sell | $1.65 | $1.55 | -5.8% | +5.8% | Correct so far |
| STXS | Sell | $1.39 | $1.30 | -6.5% | +6.5% | Correct so far |
| LRCX | Sell | $343.84 | $320.42 | -6.8% | +6.8% | Correct so far |
| PENN | Sell | $18.56 | $16.95 | -8.7% | +8.7% | Correct so far |
| RRGB | Sell | $9.51 | $8.41 | -11.5% | +11.5% | Correct so far |
| OWLT | Sell | $5.81 | $4.98 | -14.3% | +14.3% | Correct so far |
Live LF0 scorecard: The Scorecard | Research Performance dashboard
Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.
Leave a Comment